This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
Wednesday’s top analyst calls push trading as investors weigh inflation data, Fed policy, and AI-driven peers. AMD, J...
SpaceX rumors spark a rally in the Procure Space ETF, with the fund tracking the space economy as investors eye a pot...
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
Choosing between Salesforce and Braze in 2026 requires weighing scale, revenue mix, and growth prospects. This guide ...
When energy costs rise, investors often look for EV players that could benefit. This article unpack Rivian's path to ...
In a surprise move, President Trump said he would not sign the housing bill until Congress passes a separate voter-id...
A major market moment is shaping up as Dan Ives weighs in on SpaceX’s potential public debut. This article breaks dow...
A growing number of public companies are moving beyond simply accumulating crypto. This article explains why strategy...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...